Kansas City VA Medical Center - NAVREF

Kansas City, Missouri 64128

0 studies enrolling now · 1 studies all time

What they study most

Gastroesophageal Reflux Disease (GERD)

Studies at this site

• Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs) — Completed